Prostate Cancer

Associations of testosterone, sex hormone-binding globulin, and related hormones with risks of cancer death, incident cancer, and incident prostate cancer in men: individual participant data meta-analyses. June 23, 2026

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial. June 23, 2026

Surgical Complications in a large series of Retzius-sparing robot-assisted radical prostatectomy: impact of surgical experience and technical modifications (1016 cases). June 23, 2026

Current state of the art of new prostate MRI technologies and potential future developments. June 23, 2026

Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib. June 22, 2026

Association of asymptomatic PSA testing on prostate cancer mortality; a case control study in general practice. June 22, 2026

Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer. June 22, 2026

The Landscape of Prostate Tumour Methylation. June 19, 2026

AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers. June 19, 2026

Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. June 19, 2026

A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound. June 23, 2026

Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models. June 23, 2026

Investigation of Potential Splenic Metastasis on Prostate-Specific Membrane Antigen (PSMA) Imaging in High-Risk Prostate Cancer: A Role for MRI? June 23, 2026

Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study. June 22, 2026

Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation. June 22, 2026

Prostate Cancer Working Group 4 Recap. June 22, 2026

Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors. June 22, 2026

Piggybacking Towards Progress for CAR-T Cell Therapy in Prostate Cancer. June 19, 2026

CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer. June 19, 2026

Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Nonrandomized Clinical Trial. June 19, 2026

Page 1 of 1638